Elliot Gershon to Biomarkers
This is a "connection" page, showing publications Elliot Gershon has written about Biomarkers.
Connection Strength
0.409
-
Evidence from comprehensive independent validation studies for smooth pursuit dysfunction as a sensorimotor biomarker for psychosis. Sci Rep. 2024 06 15; 14(1):13859.
Score: 0.133
-
Supersensitivity to melatonin suppression by light in young people at high risk for affective disorder. A preliminary report. Neuropsychopharmacology. 1988 Sep; 1(3):217-23.
Score: 0.045
-
Differentiating biomarker features and familial characteristics of B-SNIP psychosis Biotypes. Transl Psychiatry. 2025 Aug 14; 15(1):281.
Score: 0.036
-
White Matter, Cognition, and Electrophysiological Variables in Bipolar Disorder: Using Multimodal Integration of Biomarker Variables Associated With Bipolar Disorder to Elucidate Deficits. Bipolar Disord. 2025 May; 27(3):205-216.
Score: 0.035
-
Categorical and Dimensional Approaches for Psychiatric Classification and Treatment Targeting: Considerations from Psychosis Biotypes. Adv Neurobiol. 2024; 40:685-723.
Score: 0.032
-
Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium. Schizophr Bull. 2022 01 21; 48(1):56-68.
Score: 0.028
-
Biomarker Profiles in Psychosis Risk Groups Within Unaffected Relatives Based on Familiality and Age. Schizophr Bull. 2021 07 08; 47(4):1058-1067.
Score: 0.027
-
Smooth pursuit eye movement deficits as a biomarker for psychotic features in bipolar disorder-Findings from the PARDIP study. Bipolar Disord. 2020 09; 22(6):602-611.
Score: 0.024
-
Characterizing functional regional homogeneity (ReHo) as a B-SNIP psychosis biomarker using traditional and machine learning approaches. Schizophr Res. 2020 01; 215:430-438.
Score: 0.024
-
Auditory steady-state EEG response across the schizo-bipolar spectrum. Schizophr Res. 2019 07; 209:218-226.
Score: 0.023